Vitaspring Biomedical (VSBC) Income from Continuing Operations (2017 - 2026)
Vitaspring Biomedical's Income from Continuing Operations was -$155,817 in fiscal Q2 2027 (quarter ended Jul 31, 2026), compared with -$110,845 a year earlier.
Powered by 
Analysis
Vitaspring Biomedical (VSBC) Income from Continuing Operations (2017 - 2026) Analysis & Trends
On a trailing twelve-month basis, Vitaspring Biomedical's Income from Continuing Operations was -$455,643 through Jul 31, 2026; for FY2026 (ended Jan 31, 2026), it was -$415,368.
- In earlier fiscal years, Income from Continuing Operations was -$774,922 in FY2025, -$1.12 million in FY2024, -$77,556 in FY2023 and $909,560 in FY2022.
- The fiscal Q2 2027 figure marks the lowest quarterly Income from Continuing Operations since fiscal Q3 2025.
- Per Business Quant data, VSBC's Income from Continuing Operations in the three fiscal quarters before Q2 2027 was -$75,844 (Q1 2027), -$81,464 (Q4 2026) and -$142,518 (Q3 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 5.53 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 3.62 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | -1.34 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 5.28 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 3.09 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 2.38 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -10.50 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | -246.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 1.10 Bn |
| 10 | Vitaspring Biomedical | 2.07 Mn | 2.04 Mn | - | -155,817.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | -155,817.00 |
| Apr 30, 2026 | -75,844.00 |
| Jan 31, 2026 | -81,464.00 |
| Oct 31, 2025 | -142,518.00 |
| Jul 31, 2025 | -110,845.00 |
| Apr 30, 2025 | -80,541.00 |
| Jan 31, 2025 | -143,137.00 |
| Oct 31, 2024 | -196,292.00 |
| Jul 31, 2024 | -218,662.00 |
| Apr 30, 2024 | -216,831.00 |
| Jan 31, 2024 | -225,398.00 |
| Oct 31, 2023 | -234,980.00 |
| Jul 31, 2023 | -353,583.00 |
| Apr 30, 2023 | -304,601.00 |
| Jan 31, 2023 | -4.16 Mn |
| Oct 31, 2022 | -138,281.00 |
| Jul 31, 2022 | -144,135.00 |
| Apr 30, 2022 | 276,656.00 |
| Jan 31, 2022 | 1.23 Mn |
| Oct 31, 2021 | -137,453.00 |
API Access
Vitaspring Biomedical Income from Continuing Operations API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=income-from-continuing-operations&ticker=VSBC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "income-from-continuing-operations", "ticker": "VSBC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=income-from-continuing-operations&ticker=VSBC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();